Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50

NFYS.WS

NFYS.WS Hedge Fund Activity: Q2 2022 in Review

31 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) for Q2 2022, worth a combined $15.5M — down 5.8% from $16.4M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new NFYS.WS positions and 3 closed out — a net gain of 4 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was CAAS Capital Management, opening a new position worth an estimated $237K. The largest seller was Citadel Advisors, exiting entirely with an estimated $82K sold.

• 31 institutional investors held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) as of Q2 2022, up from 27 in Q1 2022.
• Funds reported $15.5M of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 stock for Q2 2022, down 5.8% quarter-over-quarter.
• 7 funds opened new Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 positions in Q2 2022 and 3 closed out, a net change of +4 holders.
• The largest Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 buyer in Q2 2022 was CAAS Capital Management, an estimated $237K added.
• The largest Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 seller in Q2 2022 was Citadel Advisors, an estimated $82K sold.

Based on aggregated 13F filings for Q2 2022.